Published in Annu Rev Med on November 01, 2012
Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol Rev (2014) 0.97
Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family. ACS Synth Biol (2014) 0.85
HUS and TTP in Children. Pediatr Clin North Am (2013) 0.85
Evaluation of current and new biomarkers in severe preeclampsia: a microarray approach reveals the VSIG4 gene as a potential blood biomarker. PLoS One (2013) 0.81
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome. Turk J Haematol (2016) 0.77
Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature. Transpl Int (2015) 0.76
Hemolytic uremic syndrome: toxins, vessels, and inflammation. Front Med (Lausanne) (2014) 0.75
Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome. Thromb J (2016) 0.75
Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid. Sci Rep (2017) 0.75
Antepartum or immediate postpartum renal biopsies in preeclampsia/eclampsia of pregnancy: new morphologic and clinical findings. Int J Clin Exp Pathol (2014) 0.75
Periodontal and other oral manifestations of immunodeficiency diseases. Oral Dis (2016) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Atypical hemolytic-uremic syndrome. N Engl J Med (2009) 5.66
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood (2006) 4.51
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet (2010) 3.74
Atypical hemolytic uremic syndrome. Orphanet J Rare Dis (2011) 3.35
Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med (2009) 3.24
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet (2006) 3.24
Preeclampsia: recent insights. Hypertension (2005) 2.98
Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol (2012) 2.83
Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med (2012) 2.67
Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 2.66
Complement and coagulation: strangers or partners in crime? Trends Immunol (2007) 2.48
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest (2003) 2.39
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med (2006) 2.16
Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol (2008) 1.89
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum (2004) 1.87
C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis (1985) 1.64
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest (2006) 1.57
Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med (2008) 1.55
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med (2011) 1.52
Triggers of inflammation after renal ischemia/reperfusion. Clin Immunol (2006) 1.47
Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol (2012) 1.42
Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci (2007) 1.42
Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis. Thromb Haemost (2009) 1.33
Dense deposit disease. Mol Immunol (2011) 1.31
Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation (2003) 1.27
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum (2005) 1.26
Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematology Am Soc Hematol Educ Program (2011) 1.23
Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum (2012) 1.22
Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol (2008) 1.19
Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol (2008) 1.17
Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities. J Biol Chem (2011) 1.15
The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta (2008) 1.13
Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med (2010) 1.11
Complement factor H and the hemolytic uremic syndrome. J Exp Med (2007) 1.10
Complement factor H and hemolytic uremic syndrome. Int Immunopharmacol (2001) 1.10
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications. Placenta (2010) 1.08
Immunopathogenesis of ischemia/reperfusion-associated tissue damage. Clin Immunol (2011) 1.06
Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood (2008) 1.06
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol (2007) 1.05
Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation. Am J Transplant (2011) 1.05
Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol (2008) 1.05
Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes. Obstet Gynecol (2011) 1.03
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury. Kidney Int (2011) 1.00
Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost (2012) 0.94
aHUS: a disorder with many risk factors. Blood (2010) 0.92
Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS. Semin Thromb Hemost (2010) 0.90
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus (2011) 0.88
Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome. Am J Kidney Dis (2008) 0.87
Clinical grand rounds: atypical hemolytic uremic syndrome. Am J Nephrol (2012) 0.86
The role of complement in the pathogenesis of postischemic acute renal failure. Miner Electrolyte Metab (1985) 0.86
Catastrophic antiphospholipid syndrome. Rheum Dis Clin North Am (2006) 0.84
Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome. Thromb Haemost (2012) 0.83
Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP). Thromb Haemost (2009) 0.82
Pathogenesis of thrombotic microangiopathy: insights from animal models. Nephron Exp Nephrol (2009) 0.79
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol Immunol (2005) 1.67
Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med (2008) 1.55
Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant (2003) 1.50
Rep provides a second motor at the replisome to promote duplication of protein-bound DNA. Mol Cell (2009) 1.49
Promoting recruitment of minority ethnic groups into research: qualitative study exploring the views of South Asian people with asthma. J Public Health (Oxf) (2011) 1.34
Spatial bridging in a network of drug-using male sex workers. J Urban Health (2005) 1.27
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum (2005) 1.26
Synovial lipomatosis (lipoma arborescens) affecting multiple joints in a patient with congenital short bowel syndrome. J Rheumatol (2002) 1.25
Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol (2004) 1.20
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus. Arthritis Rheum (2011) 1.13
Protein-DNA complexes are the primary sources of replication fork pausing in Escherichia coli. Proc Natl Acad Sci U S A (2013) 0.99
A cluster analysis of drug use and sexual HIV risks and their correlates in a sample of African-American crack cocaine smokers with HIV infection. Drug Alcohol Depend (2008) 0.99
Micronutrient deficiencies in maternity and child health: a review of environmental and social context and implications for Malawi. Environ Geochem Health (2008) 0.97
Condom use self-efficacy among U.S. and foreign-born Latinos in Texas. J Sex Res (2004) 0.97
An investigation of concurrent sex partnering in two samples of drug users having large numbers of sex partners. Int J STD AIDS (2006) 0.96
Is contralateral exploration necessary in preterm infants with unilateral inguinal hernia? J Pediatr Surg (2006) 0.93
Differences in complement-mediated killing of Entamoeba histolytica between men and women--an explanation for the increased susceptibility of men to invasive amebiasis? Am J Trop Med Hyg (2008) 0.93
Erythrocyte selenium concentration as a marker of selenium status. Clin Nutr (2013) 0.88
Characteristics, drug use, and sex partners of a sample of male sex workers. Am J Drug Alcohol Abuse (2007) 0.87
Immunologic rheumatic disorders. J Allergy Clin Immunol (2010) 0.84
The utility of the Illness Perception Questionnaire in the evaluation of mental health practitioners' perspectives on patients with schizophrenia. J Eval Clin Pract (2009) 0.83
Analysis of health-related quality-of-life instruments measuring the impact of bariatric surgery: systematic review of the instruments used and their content validity. Patient (2011) 0.83
The use of fry (embalming fluid and PCP-laced cigarettes or marijuana sticks) among crack cocaine smokers. J Drug Educ (2008) 0.81
DNA structure specificity conferred on a replicative helicase by its loader. J Biol Chem (2009) 0.80
Codeine cough syrup use among African-American crack cocaine users. J Psychoactive Drugs (2007) 0.80
Factors associated with past research participation among low-income persons living with HIV. AIDS Patient Care STDS (2012) 0.78
Flying Start NHS™: easing the transition from student to registered health professional. J Clin Nurs (2011) 0.78
A case-control study of membrane cofactor protein mutations in two populations of patients with early pregnancy loss. J Reprod Immunol (2011) 0.75
A framework to explore micronutrient deficiency in maternal and child health in Malawi, Southern Africa. Environ Health (2009) 0.75
A psychosocial comparison of New Orleans and Houston crack smokers in the wake of Hurricane Katrina. Subst Use Misuse (2009) 0.75
3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome. Clin Endocrinol (Oxf) (2009) 0.75
Lupus (SLE): Existence and Impact of Depressive Symptomatology. Soc Work Health Care (2015) 0.75
Support for nursing and midwifery students: a special case? Nurse Educ Today (2011) 0.75
Without consent. Nurs Stand (1989) 0.75
The quality of on-line communication in a national learning programme for newly qualified nurses, midwives and allied health professionals. Nurse Educ Pract (2010) 0.75
Concurrent analysis: a pragmatic justification. Nurs Philos (2012) 0.75
Widening the gateway to nursing. Nurs Stand (1998) 0.75
Sudden onset weakness in an immunocompromised patient. J Clin Neurosci (2008) 0.75
An update to the recommended core content for sun safety messages for public education in Canada: A consensus report. Can J Public Health (2016) 0.75
Flexible frenzy. Nurs Stand (2004) 0.75
Studies on the temperature distribution of a thick film transcutaneous oxygen sensor and its thermal influences on oxygen measurement. IEEE Trans Biomed Eng (2006) 0.75